Adherence to Cognitive Behavioral Therapy for Insomnia (CBTI) Among Women Following Primary Breast Cancer Treatment: A Pilot Study

Ellyn E. Matthews, Sarah J. Schmiege, Paul F. Cook, Ann M. Berger, Mark S. Aloia

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

Cognitive behavioral therapy for insomnia (CBTI) has proven efficacy, yet 32%-89% of patients fail to consistently follow recommendations. This pilot study examines adherence to CBTI in breast cancer survivors with insomnia. There was a significant decline in adherence to prescribed rise time, and total time in bed, but no change in adherence to prescribed bedtime during six weekly sessions. Factors associated with higher adherence included lower fatigue and higher baseline motivation. Higher adherence was associated with worse subjective sleep quality at the beginning of CBTI and fewer nocturnal awakenings at the end of treatment. Results provide preliminary evidence supporting the impact of adherence on sleep outcomes such as fewer nocturnal awakenings. Attention to adherence as part of CBTI may yield greater sleep improvements.

Original languageEnglish (US)
Pages (from-to)217-229
Number of pages13
JournalBehavioral Sleep Medicine
Volume10
Issue number3
DOIs
StatePublished - Jun 2012

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Medicine (miscellaneous)
  • Psychology (miscellaneous)
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Adherence to Cognitive Behavioral Therapy for Insomnia (CBTI) Among Women Following Primary Breast Cancer Treatment: A Pilot Study'. Together they form a unique fingerprint.

Cite this